Outcomes of transconjunctival 23-gauge vitrectomy for diabetic tractionnal retinal detachment

##plugins.themes.academic_pro.article.sidebar##

Published Apr 24, 2019
Download
pdf
Vol. 97 No. 1 (2019): Issue Jan 2019

##plugins.themes.academic_pro.article.main##

Imen Zghal
Olfa Fekih
Aymen Khedri
Mehdi Hsouna Zgolli
Sonia Mabrouk
Leila Nacef

Abstract

The transconjunctival 23-gauge vitrectomy without sutures (VTCSS) combines the advantages of the 20 and 25-gauge system. It currently represents the gold standard for the surgical management of vitreoretinal pathologies, especially in diabetic patients.

Aim: Evaluate the anatomical and functional results of the VTCSS 23 gauge in diabetic tractionnal retinal detachment (DRT).
Methods: This is a retrospective study of patients undergoing vitrectomy 23 gauges from February 2015 to February 2017. Each patient a complete ophthalmological examination with collection of  pre operative peroperative and postoperative data. The vitrectomy was performed by 3 ways through the 23-gauge cannula system
Results :We collected 52 eyes presenting a DRT. The average age of patients was 50.62 years old. The average glycated hemoglobin (HBA1C) was 9.3%. The average time to treatment was 76.92 days.
The results were as follows:
For anatomical results: anatomical success rate was 92.30%.
Functionally: A significant improvement in mean AV from 1/80 to 1.25 / 10 after surgery (p = 0.022), a statistically significant correlation between the final postoperative VA and the management delay (p <0.001); significant correlation between preoperative VA and final postoperative VA (p <0.001).

Conclusion : The VTCSS 23 gauge is an effective and safe surgery for DRT  surgery in diabetic patients with a gain in time and comfort for the patient.

Keywords:

Key words : 23 gauge sutureless vitrectomy , tractionnal retinal detachment , diabetes

##plugins.themes.academic_pro.article.details##

References

  1. Machemer R, Parel JM, Norton EW. Vitrectomy: a pars plana approach. Technical improvements and further results. Trans Am Acad Ophthalmol Otolaryngol, 1972;76(2):462-6.
  2. Machemer R. A new concept for vitreous surgery. Two instrument techniques in pars plana vitrectomy. Arch Ophthalmol, 1974;92(5):407-12.
  3. The DRVS Research Group. Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management. Diabetic Retinopathy Vitrectomy Study (DRVS) report#1. Ophthalmology. 1985;92(4):492-502.
  4. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. Arch Ophthalmol.1985 ;103(11):1644—52.
  5. Sternfeld A, Axer-Siegel R, Stiebel-Kalish H, Weinberger D, Ehrlich R. Advantages of diabetictractionalretinal detachmentrepair. Clin Ophthalmol 2015;9(10):1989—94.
  6. El Annan J, Carvounis PE. Current management of vitreous hemorrhage due to proliferative diabetic retinopathy. Int Ophthalmol Clin. 2014;54(2):141—53.
  7. Oellers P, Mahmoud TH. Surgery for Proliferative Diabetic Retinopathy: New Tips and Tricks. J Ophthalmic Vis Res 2016;11(1):93—9.
  8. Meleth AD, Carvounis PE. Outcomes of vitrectomy for tractionalretinal detachment in diabetic retinopathy. Int Ophthalmol Clin. 2014;54(2):127—39.
  9. Algvere P, Persson HE,Wanger P. Preoperative electroretinograms and visual evoked cortical potentials for predicting outcome of vitrectomy in diabetics. Retina. 1985;5(3):179-83.
  10. Rice TA, Michels RG, Rice EF. Vitrectomy for diabetic traction retinal detachment involving the macula. Am J Ophthalmol. 1983;95(1):22-33.
  11. Freyler H. Combined vitrectomy and scleral resection in the therapy of massiveepiretinal fibrous membranes due to diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 1986;224(1):60-1.
  12. Miller SA, Butler JB, Myers FL,Bresnick GH. Pars plana vitrectomy. Treatment for tractional macula detachment secondary to proliferative diabetic retinopathy. Arch Ophthalmol. 1980;98(4):659-64.
  13. Tao Y, Jiang YR, Li XX, Gao L, Jonas JB. Long-term results of vitrectomy without endotampoande in proliferative diabetic retinopathy with tractional retinal detachment. Retina. 2010;30(3):447-51.
  14. Oshima Y, Shima C, Wakabayashi T,Kusaka S, Shiraga F, Ohji M et al. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology. 2009;116(5):927-38.
  15. Gupta B,Wong R, Sivaprasad S, Williamson TH et al. Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice. Eye. 2012;26(4):576-82.
  16. Kumar A, Duraipandi K, Gogia V, Sehra SV, Gupta S, Midha N. Comparativeevaluation of 23- and 25-gaugemicroincisionvitrectomysurgery in management of diabeticmaculartractionretinaldetachment. Eur J Ophthalmol. 2014;24(1):107—13.
  17. Zhao LQ, Zhu H, Zhao PQ, Hu YQ. A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy. Br J Ophthalmol. 2011;95(9):1216-22.
  18. Issa SA, Connor A, Habib M, Steel DH. Comparison of retinal breaks observed during 23 gauge transconjunctival vitrectomy versus con¬ventional 20 gauge surgery for proliferative diabetic retinopathy. Clin Ophthalmol. 2011;5(1):109-14.
  19. Yokota R, Inoue M, Itoh Y, Rii T, Hirota K, Hirakata A. Comparison of microinsicion vitrectomy and conventional 20-gaugevitrectomy for severe proliferativediabetic retinopathy. Jpn J Ophthalmol. 2015;59(5):288-94.
  20. Park DH, Shin JP, Kim SY. Comparison of clinicaloutcomes between 23-gauge and 20-gaugevitrectomy in patients with proliferativediabetic retinopathy. Retina. 2010;30(10):1662-70.
  21. Steinmetz RL, Grizzard WS, Hammer ME. Vitrectomy for diabetic traction retinal detachment using the multiport illumination system. Ophthalmology. 2002;109(12):2303-7.
  22. Lin S-J, Yeh P-T, Huang J-Y, Yang C-M. Preoperative prognostic factors in vitrectomy for severe proliferative diabetic retinopathy. 2014;44(12):174-8.